Drawing for PROSCIENTO THE METABOLIC CONTINUUM CRO

USPTO serial 99696087

PROSCIENTO THE METABOLIC CONTINUUM CRO

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
MARCY, AMY ALFIERI
Law office
TMEG LAW OFFICE 109

What this means

Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose. Watch for publication (status 686) and monitor the 30-day opposition window.

Status 680: Status 680 means the examining attorney approved your mark for publication in the USPTO Official Gazette. Publication for opposition usually follows within weeks, opening a 30-day window for third parties to oppose.

Need help with PROSCIENTO THE METABOLIC CONTINUUM CRO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jennifer Heisler Lavalley

Jennifer Heisler Lavalley GTC Law Group PC & AffiliatesOne University Avenue, Suite 302BWestwood, MA 02090United States

Goods and services

ClassDescriptionStatusFirst use
042Medical and scientific research, namely, conducting clinical trials for others; medical and scientific research services in the fields of metabolic diseases and disorders; medical research; scientific research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research and development; pharmaceutical drug and medical device development services; pharmaceutical product evaluation; consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics and pharmacogenetics; medical and scientific writing for others in the nature of technical writing; providing scientific consulting services regarding clinical research and trials; compiling scientific information regarding clinical research and trialsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 22, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 21, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 21, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Oct 21, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 21, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 21, 2026ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Oct 13, 2026PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Sep 22, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 21, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 21, 2026XAECEXAMINER'S AMENDMENT ENTERED—
Sep 21, 2026GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 21, 2026CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 29, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 29, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 29, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 14, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 14, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Aug 14, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 11, 2026DOCKASSIGNED TO EXAMINER—
Jul 9, 2026MDSMNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jul 9, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 11, 2026NWAPNEW APPLICATION ENTERED—
Mar 11, 2026MAFRAPPLICATION FILING RECEIPT MAILED—

Frequently asked questions

Related guidance